This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tech Stocks in Motion

Updated from 11:52 a.m. EDT

Shares of InVision Technologies (INVN - Get Report) were among the worst-performing technology stocks Monday after the company warned Wall Street that an internal investigation into improper payments by distributors in connection with foreign sales could jeopardize its impending acquisition by General Electric (GE).

Late Friday, the bomb detection company said it had informed the Department of Justice and Securities and Exchange Commission about its findings. As a result, the DOJ and SEC may commence an investigation into the matters, including, according to InVision, "possible violations of the Foreign Corrupt Practices Act."

The merger agreement between GE and InVision calls for the acquisition to close by Oct. 31, 2004. However, InVision warned that the internal investigation by the company and any related investigations by the government might not be completed by then. If the acquisition is not completed by Oct. 31, GE and InVision are both entitled to terminate the merger agreement. Shares of InVision Technologies traded down $6.39, or 12.9%, to $43.27.

Orbotech (ORBK) rose after the Israeli company reported stronger-than-expected second-quarter earnings and sales. The maker of optical inspection systems earned 26 cents a share on sales of $77.5 million. Analysts polled by Thomson First Call had expected it to earn 20 cents a share on sales of $72 million. A year ago, the company earned 4 cents a share on sales of $54.6 million. Shares of Orbotech traded up $1.20, or 7.1%, to $18.22.

Shares of Synopsys (SNPS) fell after the company cut its third-quarter earnings and sales outlook. Excluding items, the software company now expects to earn 31 cents to 34 cents a share, which is short of its previous forecast of 35 cents to 40 cents a share. Analysts had expected it to earn 37 cents a share. Sales, meanwhile, are now expected to be between $279 million and $283 million. Previously, it had expected sales of $300 million to $320 million. Analysts were looking for $310.2 million. The company attributed the weak outlook to lower-than-expected bookings during the quarter. Shares of Synopsys traded down $4.20, or 16.6%, to $21.05.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
NTE $4.83 1.90%
CSCO $28.89 0.00%
INVN $15.38 0.00%
INTC $32.50 0.00%
MSFT $48.03 0.00%

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs